This compound is primarily utilized in the pharmaceutical and organic synthesis industries as a key intermediate in the development of active pharmaceutical ingredients (APIs). Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group and a difluorinated piperidine ring, makes it valuable for constructing complex molecules, particularly in drug discovery. The Boc group allows for selective deprotection, enabling further functionalization of the molecule, while the difluoropiperidine moiety can enhance the metabolic stability and bioavailability of potential drug candidates. It is often employed in the synthesis of compounds targeting neurological disorders, cancer, and other therapeutic areas where fluorinated molecules are advantageous. Additionally, its carboxylic acid group provides a reactive site for coupling reactions, facilitating the creation of diverse chemical structures.